CO5200850A1 - PHARMACEUTICAL COMPOSITION FOR PROFILAXIS AND TREATMENT OF SYMPTOMS ASSOCIATED WITH THE FLU, INFLUENZA AND SIMILAR DISEASES AND PROCEDURE FOR APPLICATION - Google Patents
PHARMACEUTICAL COMPOSITION FOR PROFILAXIS AND TREATMENT OF SYMPTOMS ASSOCIATED WITH THE FLU, INFLUENZA AND SIMILAR DISEASES AND PROCEDURE FOR APPLICATIONInfo
- Publication number
- CO5200850A1 CO5200850A1 CO00057176A CO00057176A CO5200850A1 CO 5200850 A1 CO5200850 A1 CO 5200850A1 CO 00057176 A CO00057176 A CO 00057176A CO 00057176 A CO00057176 A CO 00057176A CO 5200850 A1 CO5200850 A1 CO 5200850A1
- Authority
- CO
- Colombia
- Prior art keywords
- influenza
- treatment
- profilaxis
- flu
- procedure
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Otolaryngology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
La presente invención se refiere a una composición que incluye una fitoalexina estilbénica usada en un método para la profilaxis y tratamiento de síntomas del resfriado y similares a la influenza que comprende la administración de dicha composición a un sujeto, la cual tiene la estructura: <EMI FILE="00057176_1" ID="1" IMF=JPEG > en donde R1, R2, R3, R4, R5 y R6 independientemente se seleccionan de hidrógeno e hidroxi; y sales o ésteres medicinalmente aceptables de éstos.The present invention relates to a composition that includes a stylogenic phytoalexin used in a method for the prophylaxis and treatment of cold and influenza-like symptoms comprising the administration of said composition to a subject, which has the structure: <EMI FILE = "00057176_1" ID = "1" MFI = JPEG> where R1, R2, R3, R4, R5 and R6 are independently selected from hydrogen and hydroxy; and medicinally acceptable salts or esters thereof.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36494499A | 1999-07-30 | 1999-07-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5200850A1 true CO5200850A1 (en) | 2002-09-27 |
Family
ID=23436803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO00057176A CO5200850A1 (en) | 1999-07-30 | 2000-07-31 | PHARMACEUTICAL COMPOSITION FOR PROFILAXIS AND TREATMENT OF SYMPTOMS ASSOCIATED WITH THE FLU, INFLUENZA AND SIMILAR DISEASES AND PROCEDURE FOR APPLICATION |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1221949A2 (en) |
JP (1) | JP2003505500A (en) |
CN (1) | CN1377262A (en) |
AU (1) | AU6240200A (en) |
CA (1) | CA2379703A1 (en) |
CO (1) | CO5200850A1 (en) |
HK (1) | HK1049104A1 (en) |
PE (1) | PE20010540A1 (en) |
TR (1) | TR200200246T2 (en) |
WO (1) | WO2001008671A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6878751B1 (en) | 2000-10-19 | 2005-04-12 | Imperial College Of Science Technology And Medicine | Administration of resveratrol to treat inflammatory respiratory disorders |
ITRM20020562A1 (en) * | 2002-11-06 | 2004-05-07 | Sigma Tau Ind Farmaceuti | USE OF THE RESVERATROL FOR THE PREPARATION OF A USEFUL DRUG FOR THE TREATMENT OF INFLUENCE VIRUS INFECTIONS. |
RU2007132963A (en) * | 2005-02-04 | 2009-03-10 | Петер ХЕГЕР (DE) | METHOD FOR PRODUCING HYDROXYSTILBEN CONTAINING EXTRACT OF MEDICINAL RAW MATERIAL |
EP1844784B1 (en) * | 2006-03-28 | 2010-04-21 | Epitech Group S.r.l. | A pharmaceutical composition for the treatment of pathologies caused by the general response of the immune system |
CN100453071C (en) * | 2006-11-03 | 2009-01-21 | 李万忠 | Oral resveratrol multi-phase liposome and preparation method thereof |
WO2008136173A1 (en) * | 2007-04-20 | 2008-11-13 | Ochanomizu University | Adipocyte differentiation inhibitor containing stilbene derivative as active ingredient |
ES2703737T3 (en) | 2008-01-08 | 2019-03-12 | David Rubin | Method and compositions to preserve wine |
FR2933871B1 (en) * | 2008-07-18 | 2012-12-14 | Yvery | FORMULATION FOR IMPROVING THE BIOAVAILABILITY OF A HYDROPHOBIC MOLECULE |
DK2544705T3 (en) * | 2010-03-12 | 2016-09-19 | Synairgen Res Ltd | INTERFERON BETA TO USE IN THE LOWER AIR TRANSMISSION CAUSED BY INFLUENZA |
JP5848042B2 (en) | 2011-06-29 | 2016-01-27 | 株式会社ロッテ | Eye fatigue inhibiting composition and food and drink containing the same |
US20140303260A1 (en) * | 2011-10-19 | 2014-10-09 | Nad Life Pty Ltd | Pharmaceutical compositions of resveratrol |
CN106581028A (en) * | 2016-11-30 | 2017-04-26 | 南宁市浩特竹鼠养殖场 | Western medicine for curing cold of bamboo rat and preparation method of western medicine |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0753359A (en) * | 1993-06-11 | 1995-02-28 | Kao Corp | Lipoxygenase inhibitor |
FR2778337B1 (en) * | 1998-05-05 | 2001-08-31 | Inst Nat Sante Rech Med | ARYLHYDROCARBON RECEPTOR LIGAND ANTAGONISTS |
AU4084599A (en) * | 1998-05-18 | 1999-12-06 | Oklahoma Medical Research Foundation | Resveratrol inhibition of myeloperoxidase |
US6197834B1 (en) * | 1998-09-01 | 2001-03-06 | Northeastern Ohio Universities College Of Medicine | Method of inhibiting formation of infectious herpes virus particles |
ATE324105T1 (en) * | 1998-09-08 | 2006-05-15 | Cornell Res Foundation Inc | USE OF CYCLOOXYGENASE-2 INHIBITORS TO TREAT INFLAMMATORY DISEASES OF THE HEAD AND NECK |
-
2000
- 2000-07-26 PE PE2000000750A patent/PE20010540A1/en not_active Application Discontinuation
- 2000-07-28 JP JP2001513401A patent/JP2003505500A/en not_active Withdrawn
- 2000-07-28 CN CN00810896A patent/CN1377262A/en active Pending
- 2000-07-28 TR TR2002/00246T patent/TR200200246T2/en unknown
- 2000-07-28 CA CA002379703A patent/CA2379703A1/en not_active Abandoned
- 2000-07-28 WO PCT/US2000/020658 patent/WO2001008671A2/en not_active Application Discontinuation
- 2000-07-28 AU AU62402/00A patent/AU6240200A/en not_active Abandoned
- 2000-07-28 EP EP00948987A patent/EP1221949A2/en not_active Withdrawn
- 2000-07-31 CO CO00057176A patent/CO5200850A1/en not_active Application Discontinuation
-
2002
- 2002-12-19 HK HK02109229.2A patent/HK1049104A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2003505500A (en) | 2003-02-12 |
HK1049104A1 (en) | 2003-05-02 |
CN1377262A (en) | 2002-10-30 |
WO2001008671A2 (en) | 2001-02-08 |
CA2379703A1 (en) | 2001-02-08 |
EP1221949A2 (en) | 2002-07-17 |
TR200200246T2 (en) | 2002-09-23 |
WO2001008671A3 (en) | 2002-05-02 |
AU6240200A (en) | 2001-02-19 |
PE20010540A1 (en) | 2001-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2524458T3 (en) | DNase for the treatment of male subfertility | |
AR026610A1 (en) | A PIRROLIDINACETAMIDE DERIVATIVE ONLY OR IN COMBINATION FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | |
DE60143393D1 (en) | MODIFIED FORMS PHARMACEUTICALLY ACTIVE AGENTS AND USES THEREOF | |
CO5160320A1 (en) | METHODS AND COMPOSITIONS FOR THE PREVENTION OF TOLERANCE TO MEDICINES DAS. | |
CL2008003938A1 (en) | Use of escitalopram or a pharmaceutically acceptable salt thereof to prepare a medicament useful in the treatment of post-traumatic stress disorder (divisional sol. 1799-00). | |
JP2005532372A5 (en) | ||
UY28041A1 (en) | LOW DOSE METHODS FOR THE TREATMENT OF DISORDERS IN WHICH TNFA'S ACTIVITY IS HARMFUL. | |
ATE376832T1 (en) | DELAYED RELEASE FORMULATIONS OF OXYMORPHONE | |
CO5200850A1 (en) | PHARMACEUTICAL COMPOSITION FOR PROFILAXIS AND TREATMENT OF SYMPTOMS ASSOCIATED WITH THE FLU, INFLUENZA AND SIMILAR DISEASES AND PROCEDURE FOR APPLICATION | |
BR0114799A (en) | Cyanophenoxy carboxylic acid compounds and compositions for releasing active agents | |
AR034900A1 (en) | USE OF AN EFFECTIVE AMOUNT OF A PDE4 INHIBITOR AND AN ANTI-POLINERGIC AGENT, WELL IN COMBINED FORM ONLY OR SEPARATELY, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, METHOD TO PREPARE THEM, AND USE OF A COMPOSITION THAT INCLUDES AN EFFECTIVE AMOUNT OF A PDD AN EFFECTIVE AMOUNT | |
BR9509019A (en) | Process for manufacturing pharmaceutical dosage units and tablet free of organic solvents | |
DK1296972T3 (en) | Arylmethylamine derivatives for use as tryptase inhibitors | |
DE60322075D1 (en) | PPAR ALPHA SELECTIVE COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER LIPID DISORDERS | |
ES2170143T3 (en) | COMPOSITIONS THAT INCLUDE HALOFANTRINE IN A SPECIAL FORM. | |
DK1082131T3 (en) | Immunoregulator | |
AR032614A1 (en) | CONTROLLED ORAL ADMINISTRATION SYSTEM FOR DAILY INTAKE OF CIPROFLOXACINE | |
AR039162A1 (en) | VENLAFAXINA FORMULATIONS OF EXTENDED LIBERATION | |
CO5690571A2 (en) | SYNERGIC COMBINATION INCLUDING ROFLUMILAS AND (R, R) -FORMOTEROL | |
AR018376A1 (en) | PHARMACEUTICAL COMPOSITIONS THAT CAN BE DISPERSED IN A SPONTANEOUS WAY AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT | |
NO20031650D0 (en) | New medicines for liver diseases | |
BG105984A (en) | Osanetant in the treatment of mood disorders | |
DK1227826T3 (en) | Compositions comprising an extract of Perna canaliculus, methylsulfonylmethane and glucosamide and the use thereof | |
BRPI0412506A (en) | autologous cells that induce self-tolerance of monocytically originated and their use in pharmaceutical preparations | |
DE50005714D1 (en) | PHARMACEUTICAL COMPOSITION, COMPREHENSIVE EUCALYPTUS AND ORANGE OIL |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |